Emprocell Clinical Research Private Limited - Company Profile

It is a life sciences private limited company based in Navi Mumbai, Maharashtra, India, established in 2006.

2006 Navi Mumbai, Maharashtra, India Active

Last Updated: February 10, 2026

About Emprocell Clinical Research Private Limited

Emprocell Clinical Research Private Limited, a active private limited company, was established on 24 April 2006 in Navi Mumbai, Maharashtra, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U24231MH2006PTC161334. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.61 Cr.

Formerly known as Em Pro Cell Research Private Limited. It upholds a active non-compliant status. Employing 5 professional, Its leadership includes Vasily Babiy (Director), Svetlana Babiy (Director), Viktor Radchenko (Director). Past directors included Pranav Anam Harish, Vyankatesh Jethmal Pidiyar, Olga Skrynnyk. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at C-7/1A Ttc Industrial Area, Midc, Village Pawan, E, Navi Mumbai, Maharashtra, 400705.

Company Details

CIN/LLPIN
U24231MH2006PTC161334
Registration Number
161334
Incorporation Date
24 April 2006
Authorized Capital
₹5.00 Cr
Paid-Up Capital
₹4.61 Cr
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 5.00 Cr as on 10-02-2026
Paid Up Capital ₹ 4.61 Cr as on 10-02-2026
Company Age 19 Year, 9 Months
Last Filing with ROC 31 Mar 2020
Revenue Growth **** -51.50% (FY 2020)
Profit Growth **** 14.89% (FY 2020)
Ebitda **** -3.68% (FY 2020)
Net Worth -13.59% (FY 2020)
Total Assets -8.68% (FY 2020)

Comprehensive Company Insights

Explore comprehensive insights into Emprocell Clinical Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Emprocell Clinical Research Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Vasily Babiy	Director	19 Aug 2012	Current
Svetlana Babiy	Director	09 May 2006	Current
Viktor Radchenko	Director	10 Jun 2006	Current
Volodymyr Radchenko	Director	31 Mar 2014	Current
Vladimir Evstakhievich Babiy	Director	09 May 2006	Current
Elena Babiy	Director	09 May 2006	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Alternate Director	21 Feb 2014	Past
Pramod Abcsdd	Director	15 Apr 2021	Past
Pramod Abcsdd	Director	19 Aug 2012	Past
Pramod Abcsdd	Additional Director	22 Nov 2012	Past
Pramod Abcsdd	Additional Director	22 Nov 2012	Past
Pramod Abcsdd	Additional Director	16 Dec 2014	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Emprocell Clinical Research.

Emprocell Clinical Research Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 51.5% decrease. The company also saw a substantial improvement in profitability, with a 14.89% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.59%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-51.50%

*******

Revenue from Operations

*******

-64.56%

*******

Total Assets

*******

-8.68%

*******

Profit or Loss

*******

14.89%

*******

Net Worth

*******

-13.59%

*******

EBITDA

*******

-3.68%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Emprocell Clinical Research?

In 2020, Emprocell Clinical Research had a promoter holding of 95.52% and a public holding of 4.48%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Emprocell Clinical Research?

Emprocell Clinical Research has a workforce of 5 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Emprocell Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emprocell Clinical Research's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Emprocell Clinical Research

Recent Activity within the Organization

Annual General Meeting

The activity Emprocell Clinical Research Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was completed.
31 Dec 2020
Balance Sheet

The activity Emprocell Clinical Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai. was completed.
31 Mar 2020
Director Appointment

Volodymyr Radchenko was appointed as a Director was appointed as a Director on 31 Mar 2014 & has been associated with this company since 11 years 10 months . was recorded as a recent event.
31 Mar 2014
Director Appointment

The activity Vasily Babiy was appointed as a Director was appointed as a Director on 19 Aug 2012 & has been associated with this company since 13 years 5 months . was completed.
19 Aug 2012
Director Appointment

Progress on Oleksandr Kukharchuk was appointed as a Alternate Director was appointed as a Alternate Director on 19 Aug 2012 & has been associated with this company since 13 years 5 months . was documented.
19 Aug 2012
Director Appointment

The activity Viktor Radchenko was appointed as a Director was appointed as a Director on 10 Jun 2006 & has been associated with this company since 19 years 8 months . was completed.
10 Jun 2006

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Emprocell Clinical Research Private Limited?

The CIN of Emprocell Clinical Research Private Limited is U24231MH2006PTC161334.

Where is Emprocell Clinical Research Private Limited headquartered?

Emprocell Clinical Research Private Limited is headquartered at C-7/1A Ttc Industrial Area, Midc, Village Pawan, E, Navi Mumbai, Maharashtra, 400705.

When was Emprocell Clinical Research Private Limited incorporated?

Emprocell Clinical Research Private Limited was incorporated on 24 April 2006.

Who are the current directors of Emprocell Clinical Research Private Limited?

The current directors of Emprocell Clinical Research Private Limited are

What is the primary industry of Emprocell Clinical Research Private Limited?

The primary industry of Emprocell Clinical Research Private Limited is Professional, Scientific And Technical.

Is Emprocell Clinical Research Private Limited a listed company?

Emprocell Clinical Research Private Limited is unlisted.

What is the capital structure of Emprocell Clinical Research Private Limited?

The authorized capital of Emprocell Clinical Research Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.61 Cr.

What is the compliance status of Emprocell Clinical Research Private Limited?

The compliance status of Emprocell Clinical Research Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available